Local Health Department Interest in Implementation of a Jail-Based Human Papillomavirus Vaccination Program in Kansas, Iowa, Missouri, and Nebraska.

Megha Ramaswamy, Molly Allison, Brynne Musser, Catherine Satterwhite, Robert Armstrong, Patricia J Kelly
Author Information
  1. Megha Ramaswamy: Department of Preventive Medicine and Public Health, University of Kansas School of Medicine (Drs Ramaswamy and Satterwhite, Mss Allison and Musser, and Mr Armstrong); and School of Nursing, University of Missouri Kansas City, Kansas City, Missouri (Dr Kelly).

Abstract

CONTEXT: Local health departments (LHDs) play a vital role in community vaccination programs for human papillomavirus (HPV) infection, but little research has been done to assess LHD interest in cross-sectoral partnerships to vaccinate high-risk groups, specifically incarcerated persons.
OBJECTIVE: To describe factors associated with interest in a novel implementation strategy linking LHDs with jails in 4 Midwestern states to deliver HPV vaccine.
DESIGN: Survey based on the Consolidated Framework for Implementation Research (CFIR) model given to LHD administrators. A modified Poisson relative risk regression was used to assess the relationship between independent variables and LHD interest in implementation of a jail-based HPV vaccination program.
SETTING: LHDs in Kansas, Missouri, Iowa, and Nebraska.
PARTICIPANTS: From September 2017 to April 2018, two-thirds (237/344) of invited LHD administrators from the 4 states responded to the survey.
MAIN OUTCOME MEASURE: LHD interest in implementation of a jail-based HPV vaccination program.
RESULTS: Forty-five percent of LHDs were interested in learning more about implementing a jail-based HPV vaccination program, and 2% already offered or had plans to offer HPV vaccine in their jails. Barriers to implementation were cost (66%), inmates' short incarcerations (47%), and availability of medical staffing (43%). LHD characteristics associated with interest in implementation of a jail-based HPV vaccination program included "inner setting" CFIR variables, which capture the structural and cultural context for program implementation: 7 or more employees (odds ratio [OR] = 2.22; 95% confidence interval [CI], 1.24-3.95), perception of importance to provide HPV vaccine in jails (OR = 3.70; 95% CI, 2.00-6.84), and already providing any vaccines in jails (OR = 2.62; 95% CI, 1.18-5.80).
CONCLUSIONS: Nearly half of LHDs in the region expressed interest in partnering with local entities to meet HPV vaccination needs of high-risk groups. Research on cross-sectoral partnerships and what these collaborations look like in practice is needed for public health impact.

References

  1. MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30 [PMID: 25167164]
  2. Am J Obstet Gynecol. 1968 Mar 1;100(5):607-14 [PMID: 5638481]
  3. Subst Abuse Treat Prev Policy. 2013 Oct 31;8:37 [PMID: 24175959]
  4. Vaccine. 2018 Aug 6;36(32 Pt A):4783-4791 [PMID: 29551226]
  5. Public Health Rep. 2016 Jan-Feb;131(1):52-8 [PMID: 26843670]
  6. J Public Health Manag Pract. 2019 Jan/Feb;25(1):5-6 [PMID: 30507793]
  7. Implement Sci. 2009 Aug 07;4:50 [PMID: 19664226]
  8. Implement Sci. 2018 Mar 27;13(1):52 [PMID: 29587804]
  9. Lancet. 2009 Jun 6;373(9679):1949-57 [PMID: 19493565]
  10. J Infect Dis. 2009 Apr 1;199(7):936-44 [PMID: 19236277]
  11. J Public Health Manag Pract. 2019 May/Jun;25(3):229-237 [PMID: 30234670]
  12. Am J Public Health. 2018 Aug;108(8):1000-1002 [PMID: 29927651]
  13. Am J Prev Med. 2017 Jan;52(1):64-73 [PMID: 27816382]
  14. MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):909-917 [PMID: 30138305]
  15. Health Educ Behav. 2015 Apr;42(1 Suppl):46S-56S [PMID: 25829117]
  16. Lancet Oncol. 2016 Jan;17(1):67-77 [PMID: 26652797]
  17. Int J Health Policy Manag. 2014 May 13;2(4):193-7 [PMID: 24847486]
  18. Sex Transm Dis. 2015 Feb;42(2):71-5 [PMID: 25585064]
  19. J Health Hum Serv Adm. 2012 Spring;34(4):418-55 [PMID: 22530285]
  20. J Adolesc Health. 2010 May;46(5):495-8 [PMID: 20413087]
  21. Public Health Rep. 2016 Jan-Feb;131(1):7-10 [PMID: 26843663]
  22. J Womens Health (Larchmt). 2011 Dec;20(12):1839-45 [PMID: 22004180]
  23. Implement Sci. 2013 May 10;8:51 [PMID: 23663819]
  24. J Epidemiol Community Health. 2009 Nov;63(11):912-9 [PMID: 19648129]

Grants

  1. R21 CA204767/NCI NIH HHS

MeSH Term

Cross-Sectional Studies
Humans
Iowa
Kansas
Local Government
Missouri
Nebraska
Papillomavirus Infections
Papillomavirus Vaccines
Prisons
Public Health

Chemicals

Papillomavirus Vaccines

Word Cloud

Created with Highcharts 10.0.0HPVvaccinationLHDinterestLHDsimplementationprogramjailsjail-basedvaccine=295%Localhealthassesscross-sectoralpartnershipshigh-riskgroupsassociated4statesImplementationResearchCFIRadministratorsvariablesKansasMissouriIowaNebraskaalready1ORCICONTEXT:departmentsplayvitalrolecommunityprogramshumanpapillomavirusinfectionlittleresearchdonevaccinatespecificallyincarceratedpersonsOBJECTIVE:describefactorsnovelstrategylinkingMidwesterndeliverDESIGN:SurveybasedConsolidatedFrameworkmodelgivenmodifiedPoissonrelativeriskregressionusedrelationshipindependentSETTING:PARTICIPANTS:September2017April2018two-thirds237/344invitedrespondedsurveyMAINOUTCOMEMEASURE:RESULTS:Forty-fivepercentinterestedlearningimplementing2%offeredplansofferBarrierscost66%inmates'shortincarcerations47%availabilitymedicalstaffing43%characteristicsincluded"innersetting"capturestructuralculturalcontextimplementation:7employeesoddsratio[OR]22confidenceinterval[CI]24-395perceptionimportanceprovide37000-684providingvaccines6218-580CONCLUSIONS:NearlyhalfregionexpressedpartneringlocalentitiesmeetneedscollaborationslooklikepracticeneededpublicimpactHealthDepartmentInterestJail-BasedHumanPapillomavirusVaccinationProgram

Similar Articles

Cited By